14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.94 $1.73 Friday, 3rd May 2024 ABVC stock ended at $1.08. This is 6.09% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 7.48% from a day low at $1.07 to a day high of $1.15.
90 days $0.94 $1.73
52 weeks $0.333 $6.87

Historical ABVC BioPharma, Inc. prices

Date Open High Low Close Volume
May 03, 2024 $1.15 $1.15 $1.07 $1.08 413 022
May 02, 2024 $1.12 $1.17 $1.10 $1.15 292 505
May 01, 2024 $1.19 $1.23 $1.05 $1.13 931 477
Apr 30, 2024 $1.34 $1.40 $1.25 $1.25 679 802
Apr 29, 2024 $1.39 $1.45 $1.30 $1.40 1 737 947
Apr 26, 2024 $1.49 $1.57 $1.40 $1.42 2 003 930
Apr 25, 2024 $1.45 $1.73 $1.36 $1.59 5 257 641
Apr 24, 2024 $1.46 $1.50 $1.28 $1.48 6 264 561
Apr 23, 2024 $1.01 $1.37 $1.01 $1.35 7 137 328
Apr 22, 2024 $0.99 $1.04 $0.94 $1.04 307 886
Apr 19, 2024 $1.04 $1.04 $0.97 $0.99 162 765
Apr 18, 2024 $1.08 $1.08 $0.94 $1.05 455 760
Apr 17, 2024 $1.15 $1.19 $1.00 $1.02 1 772 840
Apr 16, 2024 $1.06 $1.13 $1.05 $1.12 109 462
Apr 15, 2024 $1.10 $1.11 $1.05 $1.09 218 098
Apr 12, 2024 $1.15 $1.15 $1.08 $1.09 221 067
Apr 11, 2024 $1.10 $1.17 $1.10 $1.15 263 119
Apr 10, 2024 $1.29 $1.30 $1.06 $1.14 3 769 330
Apr 09, 2024 $1.24 $1.26 $1.17 $1.18 248 841
Apr 08, 2024 $1.30 $1.31 $1.25 $1.25 152 404
Apr 05, 2024 $1.27 $1.30 $1.25 $1.27 67 490
Apr 04, 2024 $1.26 $1.31 $1.25 $1.28 114 344
Apr 03, 2024 $1.29 $1.29 $1.24 $1.29 126 081
Apr 02, 2024 $1.35 $1.35 $1.25 $1.29 202 970
Apr 01, 2024 $1.28 $1.41 $1.28 $1.37 644 432
Click to get the best stock tips daily for free!

About ABVC BioPharma, Inc.

ABVC BioPharma. ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for attention deficit hyperactivity d... ABVC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT